Icotrokinra is a first-in-class investigational targeted oral peptide that selectively blocks the IL-23 receptor 1 Filing ...

DISCOVER study (clinical study identifier: NCT05590585): an analysis evaluating the impact of Dupixent on skin structure in individuals with skin of colour, including lesions and epidermal thickness, ...

A federal judge on Monday approved a plan to settle a lawsuit filed by President Donald Trump’s Justice Department that ...

European expansion in September across Georgia, Italy, Lithuania, Poland, Romania, Spain, and US13 subjects recruited (treated, enrolled, or ...

First patient dosed with [212Pb]VMT01 3.0 mCi in combination with nivolumab[212Pb]VMT01 3.0 mCi single agent dose Cohort re-openedSEATTLE, Sept.

Hayden Homes just received a major national honor. It ranked #3 on Fortune Magazine's 2025 Best Workplaces in Construction list. It made that list for the 2nd time. The company also ranked #21 on ...

Sept. 15 was chosen as the starting point to coincide with the anniversary of “El Grito de Dolores,” or the “Cry of Dolores,” ...

Job action hasn't affected liquor and cannabis distribution so far but the industry still has fresh memories of a 2022 BCGEU strike that shut down distribution warehouses.

Icotrokinra is a first-in-class investigational targeted oral peptide that selectively blocks the IL-23 receptor 1Filing based on four Phase 3 studies that met all primary and co-primary endpoints. Th ...

After a mathematics win in July, Gemini 2.5 Deep Think has now scored a gold-medal level performance in competitive coding.